Skip to main content
. 2012 Jan 12;27(4):1035–1040. doi: 10.3892/or.2012.1635

Figure 2.

Figure 2

Dose-dependent inhibition of the viability of MPC-11 cells treated with CPT-TMC and CPT. MPC-11 cells were treated with various doses of CPT-TMC and CPT for 48 h. During the assays, the CPT dose in the CPT-TMC was always the same as that of free CPT. Cell viability was detected by MTT assays. Data are expressed as mean ± SD. No significant difference was observed between the CPT-TMC and the CPT group (P>0.05).